These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 947944)

  • 1. Uptake of 131I-19-iodocholesterol by an adrenal cortical carcinoma and its metastases.
    Chatal JF; Charbonnel B; Le Mevel BP; Guihard D
    J Clin Endocrinol Metab; 1976 Jul; 43(1):248-51. PubMed ID: 947944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Localization of a virilizing adrenal carcinoma by 131I-19-iodocholesterol scintigraphy.
    Barbarino A; Perrelli L; Menini E; De Marinis L; Bonomo L; Pasargiklian E
    J Nucl Biol Med; 1976; 20(4):172-5. PubMed ID: 1025302
    [No Abstract]   [Full Text] [Related]  

  • 3. [Value of isotopic exploration using 131-I-19 iodocholesterol in a case of malignant cortico-surrenaromy].
    Chatal JF; Bureau L; Buzelin JM; Ordronneau J; Charbonnel B; Guenel J
    Ann Med Interne (Paris); 1975 Mar; 126(3):171-6. PubMed ID: 1122087
    [No Abstract]   [Full Text] [Related]  

  • 4. 131I-19-iodocholesterol visualization of an adrenal carcinoma without clinical manifestations.
    Bossuyt A; Somers G
    J Nucl Biol Med; 1975; 19(4):225-7. PubMed ID: 1223256
    [No Abstract]   [Full Text] [Related]  

  • 5. Localization of a metastatic adrenal carcinoma using 131-I-19-iodocholesterol.
    Forman BH; Antar MA; Touloukian RJ; Mulrow PJ; Genel M
    J Nucl Med; 1974 May; 15(5):332-4. PubMed ID: 4823265
    [No Abstract]   [Full Text] [Related]  

  • 6. Iodocholesterol adrenal tissue uptake and imaging adrenal neoplasms.
    Schteingart DE; Seabold JE; Gross MD; Swanson DP
    J Clin Endocrinol Metab; 1981 Jun; 52(6):1156-61. PubMed ID: 7229000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Location of aldosterone-producing adenomas with 131I-19-iodocholesterol.
    Hogan MJ; McRae J; Schambelan M; Biglieri EG
    N Engl J Med; 1976 Feb; 294(8):410-4. PubMed ID: 1246308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Photoscintigraphy using I 131-19-iodocholesterol in the diagnosis of adrenal gland diseases (case reports)].
    Fresco G; Bagnasco M; Fontana B; Ferrini O
    Arch Maragliano Patol Clin; 1974; 30(1):87-107. PubMed ID: 4480701
    [No Abstract]   [Full Text] [Related]  

  • 9. Adrenal scintigraphy with 131I-19-iodocholesterol.
    Hoefnagels WH; Claessens RA; Beex LV; Smals AG; Drayer JI; Kazem I; Kloppenborg PW
    Neth J Med; 1976; 19(6):261-6. PubMed ID: 1004667
    [No Abstract]   [Full Text] [Related]  

  • 10. [Scintigraphy using iodine-131-labeled 19-iodocholesterol in the study of adrenal pathology].
    Lacourcière Y; Tremblay RR; Bélanger CG; Bernier JP
    Union Med Can; 1975 Mar; 104(3):395-9. PubMed ID: 1162769
    [No Abstract]   [Full Text] [Related]  

  • 11. [Adrenal gland scanning with 131I-19-iodocholesterol (author's transl)].
    Tragl KH; Angelberger P; Imhof H; Wiesinger F
    Wien Klin Wochenschr; 1973 Dec; 85(49):806-9. PubMed ID: 4356594
    [No Abstract]   [Full Text] [Related]  

  • 12. A new and superior adrenal imaging agent, 131I-6beta-iodomethyl-19-nor-cholesterol (NP-59): evaluation in humans.
    Sarkar SD; Cohen EL; Beierwaltes WH; Ice RD; Cooper R; Gold EN
    J Clin Endocrinol Metab; 1977 Aug; 45(2):353-62. PubMed ID: 885997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scintigraphic detection of hepatic metastases with 131I-labeled steroid in recurrent adrenal carcinoma: case report.
    Watanabe K; Kamoi I; Nakayama C; Koga I; Matsuura K
    J Nucl Med; 1976 Oct; 17(10):904-6. PubMed ID: 966060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of 131I-19-iodocholesterol scintigraphy and ultrasonography in the localization of a poorly vascularized phaeochromocytoma.
    Troncone L; Falappa PG; Cavallaro A; Netri G
    Br J Radiol; 1981 Apr; 54(640):353-5. PubMed ID: 7225727
    [No Abstract]   [Full Text] [Related]  

  • 15. A new and superior adrenal scanning agent, NP-59.
    Sarkar SD; Beierwaltes H; Ice RD; Basmadjian GP; Hetzel KR; Kennedy WP; Mason MM
    J Nucl Med; 1975 Nov; 16(11):1038-42. PubMed ID: 1185265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of metastatic adrenal carcinoma using 131I-6-beta-iodomethyl-19-norcholesterol total body scans.
    Seabold JE; Haynie TP; DeAsis DN; Samaan NA; Glenn HJ; Jahns MF
    J Clin Endocrinol Metab; 1977 Oct; 45(4):788-97. PubMed ID: 410824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of the reliability of 131I-19-iodocholesterol scintigraphic examination in the diagnosis of adrenal tumors].
    Troncone L; Galli G; Focacci C
    Radiol Med; 1980 Nov; 66(11):841-2. PubMed ID: 7221053
    [No Abstract]   [Full Text] [Related]  

  • 18. [The diagnosis of adrenal glands adenoma with 131-I 19 iodocholesterol scanning (author's transl)].
    Contini C; Calbiani B; Calestini P
    Ateneo Parmense Acta Biomed; 1976; 47(6):665-74. PubMed ID: 1016563
    [No Abstract]   [Full Text] [Related]  

  • 19. [A new radiotracer for scintigraphy of the adrenal glands: 6-methyl-Se75-selenocholesterol. Its value in comparison with 131-I-19-iodocholesterol].
    Chatal JF; Charbonnel B; Guihard R
    Nouv Presse Med; 1977 Apr; 6(13):1145. PubMed ID: 850632
    [No Abstract]   [Full Text] [Related]  

  • 20. Adrenal imaging with radioiodocholesterol in the diagnosis of adrenal disorders.
    Anderson BG; Beierwaltes WH
    Adv Intern Med; 1974; 19():327-43. PubMed ID: 4815290
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.